Loading…
Encompass Health Corporation is projected to rise to $120.18 by 2027, a +15% move from its current price of $104.29. EHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $103.06 | $104.31 | $105.59 | +0.02% |
| May 30 | $102.57 | $104.34 | $106.14 | +0.05% |
| May 31 | $102.20 | $104.36 | $106.58 | +0.07% |
| Jun 1 | $101.89 | $104.39 | $106.95 | +0.09% |
| Jun 2 | $101.62 | $104.41 | $107.28 | +0.12% |
| Jun 3 | $101.38 | $104.44 | $107.58 | +0.14% |
| Jun 4 | $101.17 | $104.46 | $107.86 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $101.17 | $104.46 | $107.86 | +0.16% |
| Week 2 | $100.00 | $104.63 | $109.49 | +0.33% |
| Week 3 | $99.15 | $104.81 | $110.79 | +0.49% |
| Week 4 | $98.46 | $104.98 | $111.93 | +0.66% |
| Week 5 | $97.88 | $105.15 | $112.97 | +0.83% |
| Week 6 | $97.37 | $105.32 | $113.93 | +0.99% |
| Week 7 | $96.92 | $105.50 | $114.84 | +1.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company provides specialized rehabilitative treatment on an inpatient basis, using technology and therapy to help patients recover from major injuries or illnesses regain functional ability, independence, and quality of life, along with medical, nursing, therapy, and ancillary services. The organization serves patients through Medicare, managed care plans and private insurers, state governments, and other patients.
It was formerly HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health was incorporated in 1984 and is based in Birmingham, Alabama.
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico and is categorized within the Healthcare sector. The current price is $104.96 per share, and the company carries a market capitalization of $10.41B with a market rank of 892. The stock trades in relation to modest moving-average levels, with a SMA50 of $103.16 and a SMA200 of $111.19.
The forecast picture suggests upside potential over the long term, with the 2026 average price at $104.96 and the trajectory rising to $159.58 by 2030, $427.82 by 2040, and $814.82 by 2050. The longer horizon carries bullish sentiment through 2031-2050, with ROI figures reaching 52 by 2030, 307.6 by 2040, and 676.3 by 2050.
A major floor 10.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.1% below — buyers have tended to step in here.
The nearest ceiling, 3.6% above — a clean break opens room to run.
A major ceiling 8.8% above — clearing it would confirm fresh momentum.
Key EHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $104.92 | Sell | $104.88 | Sell |
| MA 10 | $105.69 | Sell | $105.23 | Sell |
| MA 20 | $105.50 | Sell | $105.16 | Sell |
| MA 50 | $103.31 | Buy | $104.58 | Sell |
| MA 100 | $103.43 | Buy | $105.43 | Sell |
| MA 200 | $111.07 | Sell | $107.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.73 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -57.48 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.30 | Sell |
| ROC (12) | -1.71 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | -0.21 | Sell |
| Ultimate (7,14,28) | 37.56 | Neutral |
| Momentum (10) | -3.79 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 104.34 | Sell |
| ADX (14) | 9.89 | Neutral |
| ATR (14) | 1.14 | Info |
Near-term technical picture is NEUTRAL. RSI14 is 50. The 50-day moving average is $103.16, while the 200-day moving average sits at $111.19. The stock has a defined support at $100.00 and a resistance at $108.08. In the last 30 days, the price has traded in a range of $96.45 to $114.22, reflecting modest volatility around a neutral baseline.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $93.83 | $104.29 | $144.60 | 0% | Neutral | |
| $98.18 | $120.18 | $153.99 | +15% | Neutral | |
| $107.14 | $133.54 | $175.58 | +28% | Bullish | |
| $118.62 | $150.10 | $201.45 | +44% | Bullish | |
| $121.19 | $155.38 | $212.23 | +49% | Bullish | |
| $145.67 | $189.03 | $262.22 | +81% | Bullish | |
| $168.42 | $221.00 | $310.87 | +112% | Bullish | |
| $175.97 | $233.32 | $332.40 | +124% | Bullish | |
| $187.56 | $251.15 | $362.04 | +141% | Bullish | |
| $188.70 | $255.05 | $371.72 | +145% | Bullish | |
| $286.63 | $404.00 | $616.87 | +287% | Bullish | |
| $508.19 | $768.08 | $1,256.79 | +636% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $93.83 | $104.29 | $122.13 | +0.00% |
| June 2026 | $89.47 | $104.37 | $124.11 | +0.08% |
| July 2026 | $90.81 | $106.55 | $127.90 | +2.09% |
| August 2026 | $94.48 | $111.35 | $134.64 | +4.51% |
| September 2026 | $95.63 | $113.12 | $137.60 | +1.59% |
| October 2026 | $95.09 | $112.87 | $138.03 | -0.22% |
| November 2026 | $96.70 | $115.13 | $141.45 | +2.00% |
| December 2026 | $98.14 | $117.17 | $144.60 | +1.77% |
Click any year to see its month-by-month EHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect EHC to range from $93.83 to $144.60 through 2026. The $104.29 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The EHC price prediction for 2027 points to an average of $120.18 (low $98.18, high $153.99) — a potential gain of +15% on today's $104.29. Price action looks broadly range-bound.
In 2028, EHC is projected to trade between $107.14 and $175.58, averaging $133.54 — a potential gain of +28% from today's $104.29. That is up +11% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Encompass Health Corporation's 2029 outlook centres on $150.10, within a $118.62 to $201.45 range. That is up +12% on the projected 2028 average. That marks a +44% change versus current levels. Momentum favours further upside here.
By 2030, EHC could reach as high as $212.23, with a base case around $155.38 and support toward $121.19 — roughly +49% from $104.29. Buyers look set to stay in control over this stretch.
Expect EHC to range from $145.67 to $262.22 through 2031. The $189.03 average target implies a +81% move from current prices. That is up +22% on the projected 2030 average. Momentum favours further upside here.
The EHC price prediction for 2032 points to an average of $221.00 (low $168.42, high $310.87) — a potential gain of +112% on today's $104.29. Buyers look set to stay in control over this stretch.
In 2033, EHC is projected to trade between $175.97 and $332.40, averaging $233.32 — a potential gain of +124% from today's $104.29. That is up +6% on the projected 2032 average. Momentum favours further upside here.
Encompass Health Corporation's 2034 outlook centres on $251.15, within a $187.56 to $362.04 range. That is up +8% on the projected 2033 average. That marks a +141% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, EHC could reach as high as $371.72, with a base case around $255.05 and support toward $188.70 — roughly +145% from $104.29. Momentum favours further upside here.
Expect EHC to range from $286.63 to $616.87 through 2040. The $404.00 average target implies a +287% move from current prices. That is up +58% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The EHC price prediction for 2050 points to an average of $768.08 (low $508.19, high $1,256.79) — a potential gain of +636% on today's $104.29. Momentum favours further upside here.
Investing $1,000 in EHC today (≈ 9.588647 EHC) could be worth
$7,364.86
+$6,364.86 (+636%) by 2050 · US Dollar
Based on the average projected EHC price of $768.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EHCwould be worth at today's price.
$1,000 invested in EHC on May 27, 2025 (≈ 8.26378 EHC) would be worth
$861.83
-$138.17 (-13.8%) today · 0.86× · US Dollar
Based on a EHC entry price of $121.01 vs. today's $104.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $105.99 | $983.96 | -1.6% |
| 1 month ago | $100.92 | $1,033.39 | +3.3% |
| 3 months ago | $107.2 | $972.85 | -2.7% |
| 6 months ago | $116.22 | $897.35 | -10.3% |
| 1 year ago | $121.01 | $861.83 | -13.8% |
| All time (5.0y) ago | $68.33 | $1,526.28 | +52.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EHC forecast.
Our base-case forecast reaches $210.00 around 2032.
Implied market cap at $210.00: $20.83B
The multi-year forecast depicts a bullish trajectory beyond 2026, with the average price rising from $104.96 in 2026 to $159.58 by 2030, then to $427.82 by 2040 and $814.82 by 2050. The corresponding ROI figures are 0 for 2026, 52 for 2030, 307.6 for 2040, and 676.3 for 2050. Sentiment shifts to BULLISH from 2028 onward, suggesting meaningful upside potential over the longer horizon.
As with all forecasts, these estimates are not guarantees and are subject to market risk and volatility.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $159.58, with a min of $124.44 and a max of $218.02, and an ROI of 52. The sentiment is BULLISH.
The long-run forecast points to a bullish trajectory, with 2040 average price of $427.82 and 2050 average price of $814.82, and ROIs of 307.6 and 676.3 respectively. The 2026 average is $104.96, and the 2028- onwards period is labeled BULLISH, though these are estimates and not guarantees.
Yes. The 2029 average price is $153.79, and the 2028 average is $136.85, indicating the threshold of $150 is surpassed in 2029 on average.
Near-term sentiment is NEUTRAL. RSI14 is 50, SMA50 is $103.16, SMA200 is $111.19, with support at $100.00 and resistance at $108.08. The 30-day range is $96.45 to $114.22.
Current price is $104.96, market cap is $10.41B, and market rank is 892.
Encompass Health Corporation Community Discussion
0Share your Encompass Health Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.